BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 26039325)

  • 1. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
    Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
    Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Liu X; Jiang L; Zeng H; Gao L; Guo S; Chen C; Liu X; Zhang M; Ma L; Li Y; Qi X; Wu Y
    Autophagy; 2024 May; 20(5):1072-1097. PubMed ID: 38050963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin promotes podocyte autophagy and ameliorates renal injury in diabetic mice.
    Xiao T; Guan X; Nie L; Wang S; Sun L; He T; Huang Y; Zhang J; Yang K; Wang J; Zhao J
    Mol Cell Biochem; 2014 Sep; 394(1-2):145-54. PubMed ID: 24850187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
    Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
    Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paecilomyces cicadae-fermented Radix astragali activates podocyte autophagy by attenuating PI3K/AKT/mTOR pathways to protect against diabetic nephropathy in mice.
    Yang F; Qu Q; Zhao C; Liu X; Yang P; Li Z; Han L; Shi X
    Biomed Pharmacother; 2020 Sep; 129():110479. PubMed ID: 32768963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renoprotection From Diabetic Complications in OVE Transgenic Mice by Endothelial Cell Specific Overexpression of Metallothionein: A TEM Stereological Analysis.
    Carlson EC; Chhoun JM; Grove BD; Laturnus DI; Zheng S; Epstein PN; Tan Y
    Anat Rec (Hoboken); 2017 Mar; 300(3):560-576. PubMed ID: 27813325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes.
    Yoshibayashi M; Kume S; Yasuda-Yamahara M; Yamahara K; Takeda N; Osawa N; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Asanuma K; Maegawa H; Araki SI
    Biochem Biophys Res Commun; 2020 Apr; 525(2):319-325. PubMed ID: 32089264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
    Ziyadeh FN; Wolf G
    Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the tunneling nanotube-TNFAIP2/M-sec system on podocyte autophagy in diabetic nephropathy.
    Barutta F; Bellini S; Kimura S; Hase K; Corbetta B; Corbelli A; Fiordaliso F; Bruno S; Biancone L; Barreca A; Papotti MG; Hirsh E; Martini M; Gambino R; Durazzo M; Ohno H; Gruden G
    Autophagy; 2023 Feb; 19(2):505-524. PubMed ID: 35659195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spironolactone alleviates diabetic nephropathy through promoting autophagy in podocytes.
    Dong D; Fan TT; Ji YS; Yu JY; Wu S; Zhang L
    Int Urol Nephrol; 2019 Apr; 51(4):755-764. PubMed ID: 30734886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.
    Carlson EC; Chhoun JM; Laturnus DI; Bikash KC; Berg B; Zheng S; Epstein PN
    Diabetes Metab Res Rev; 2013 Feb; 29(2):113-24. PubMed ID: 22926941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
    Fu J; Lee K; Chuang PY; Liu Z; He JC
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F287-97. PubMed ID: 25411387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemigliptin improves renal function and attenuates podocyte injury in mice with diabetic nephropathy.
    Jung E; Kim J; Ho Kim S; Kim S; Cho MH
    Eur J Pharmacol; 2015 Aug; 761():116-24. PubMed ID: 25977232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte detachment and reduced glomerular capillary endothelial fenestration promote kidney disease in type 2 diabetic nephropathy.
    Weil EJ; Lemley KV; Mason CC; Yee B; Jones LI; Blouch K; Lovato T; Richardson M; Myers BD; Nelson RG
    Kidney Int; 2012 Nov; 82(9):1010-7. PubMed ID: 22718189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.
    Inoki K; Mori H; Wang J; Suzuki T; Hong S; Yoshida S; Blattner SM; Ikenoue T; Rüegg MA; Hall MN; Kwiatkowski DJ; Rastaldi MP; Huber TB; Kretzler M; Holzman LB; Wiggins RC; Guan KL
    J Clin Invest; 2011 Jun; 121(6):2181-96. PubMed ID: 21606597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice.
    Gödel M; Hartleben B; Herbach N; Liu S; Zschiedrich S; Lu S; Debreczeni-Mór A; Lindenmeyer MT; Rastaldi MP; Hartleben G; Wiech T; Fornoni A; Nelson RG; Kretzler M; Wanke R; Pavenstädt H; Kerjaschki D; Cohen CD; Hall MN; Rüegg MA; Inoki K; Walz G; Huber TB
    J Clin Invest; 2011 Jun; 121(6):2197-209. PubMed ID: 21606591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diabetic microenvironment causes mitochondrial oxidative stress in glomerular endothelial cells and pathological crosstalk with podocytes.
    Casalena GA; Yu L; Gil R; Rodriguez S; Sosa S; Janssen W; Azeloglu EU; Leventhal JS; Daehn IS
    Cell Commun Signal; 2020 Jul; 18(1):105. PubMed ID: 32641054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.